3891 - 3900 of 7965 Results
Title
Year
- Duration of Symptom Relief Between Injections for AbobotulinumtoxinA (Dysport®) in Spastic Paresis and Cervical Dystonia: Comparison of Evidence From Clinical Studies2020OPENTitle: Duration of Symptom Relief Between Injections for AbobotulinumtoxinA (Dysport®) in Spastic Paresis and Cervical Dystonia: Comparison of Evidence From Clinical StudiesJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2020.576117Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2020.576117/pdfCitation Count: 17
-
OPENTitle: GBA-Associated Synucleinopathies: Prime Candidates for Alpha-Synuclein Targeting CompoundsJournal Name: Frontiers in Cell and Developmental BiologyPublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcell.2020.562522Best OA location URL: https://www.frontiersin.org/articles/10.3389/fcell.2020.562522/pdfCitation Count: 10
-
OPENTitle: Analysis of Heterozygous PRKN Variants and Copy‐Number Variations in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 178End Page: 187Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28299Best OA location URL: https://www.medrxiv.org/content/medrxiv/early/2020/08/20/2020.05.07.20072728.full.pdfCitation Count: 40
-
OPENTitle: Longitudinal association between dopamine agonists and weight in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 80Issue #:Start Page: 158End Page: 164Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.09.037Best OA location URL: http://manuscript.elsevier.com/S1353802020307690/pdf/S1353802020307690.pdfCitation Count: 5
-
OPENTitle: Quality improvement in neurologyJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 95Issue #: 19Start Page: 866End Page: 873Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000010634Best OA location URL: https://n.neurology.org/content/neurology/95/19/866.full.pdfCitation Count: 16
-
OPENTitle: Non‐coding variants in MYH11, FZD3, and SORCS3 are associated with dementia in womenJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 17Issue #: 2Start Page: 215End Page: 225Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.12181Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920533Citation Count: 23
- Blinded RT‐QuIC Analysis of α‐Synuclein Biomarker in Skin Tissue From Parkinson's Disease Patients2020OPENTitle: Blinded RT‐QuIC Analysis of α‐Synuclein Biomarker in Skin Tissue From Parkinson's Disease PatientsJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 12Start Page: 2230End Page: 2239Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28242Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749035Citation Count: 99
- Fast Purification of Recombinant Monomeric Amyloid-β from E. coli and Amyloid-β-mCherry Aggregates from Mammalian Cells2020OPENTitle: Fast Purification of Recombinant Monomeric Amyloid-β from E. coli and Amyloid-β-mCherry Aggregates from Mammalian CellsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 11Issue #: 20Start Page: 3204End Page: 3213Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.0c00300Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.0c00300Citation Count: 5
-
RESTRICTEDTitle: Gaps, Controversies, and Proposed Roadmap for Research in Normal Pressure HydrocephalusJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 11Start Page: 1945End Page: 1954Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28251Citation Count: 36
- How specific are the conformation-specific α-synuclein antibodies? Characterization and validation of 16 α-synuclein conformation-specific antibodies using well-characterized preparations of α-synuclein monomers, fibrils and oligomers with distinct structures and morphology2020OPENTitle: How specific are the conformation-specific α-synuclein antibodies? Characterization and validation of 16 α-synuclein conformation-specific antibodies using well-characterized preparations of α-synuclein monomers, fibrils and oligomers with distinct structures and morphologyJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 146Issue #:Start Page: 105086End Page: 105086Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2020.105086Best OA location URL: https://doi.org/10.1016/j.nbd.2020.105086Citation Count: 112